Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript November 7, 2024
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.08.
Operator: Thank you for standing by. My name is Louella, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q3 2024 Investor Update Conference Call. All lines have been placed on mute to prevent any background...
